ATRA · Atara Biotherapeutics, Inc. · Supply Chain
$8.96
-0.22 (-2.40%)
At close · Oct 19
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our existing cash, cash equivalents and short-term investments as of June 30, 2026 will not be sufficient to fund our planned operations for at least the next twelve months from the date of issuance of these financial statements. These conditions raise substantial doubt about our ability to continue as a going concern for at least 12 months after the issuance of the accompanying condensed consolidated financial statements.”View the 10-Q filed Aug 12, 2026
Market Cap
$92.75M
Shares
10.04M
Volume · Oct 19
12.46K
Avg daily vol (3M)
46.52K
Supply Chain
Customers, suppliers, competitors and partners named in annual 10-K reports: ATRA's own, and those of other companies that name ATRA.
Read supply chains in your AI or your code through MCP and the API →
Pro
See who ATRA sells to, buys from and competes with
- 0 suppliers
- 1 customer
- 12 competitors
Pro names each company, links it to its own page, shows any revenue share the filing states, and quotes the sentence it comes from.